Semaglutide (5mg/10mg/15mg)
The #1 Research Peptide in the World
Order Semaglutide (5mg/10mg/15mg) online for laboratory research. Compare the listed vial options and current price, then add your selection to cart and continue to checkout. Review available COA records for the exact product, strength and lot. Research Use Only; not for human or veterinary use.
Semaglutide is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 5mg / 10mg / 15mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
Research Applications & Benefits
- Most clinically validated GLP-1 agonist
- Appetite regulation & satiety signaling
- Cardiovascular benefit data
- Once-weekly dosing research
What is Semaglutide?
Semaglutide is a peptide analogue of GLP-1, a hormone involved in glucose and appetite signaling. This page offers research vial contents of 5mg, 10mg and 15mg, not a pharmaceutical formulation.
Listed vial contents: 5mg / 10mg / 15mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
What mechanisms are being studied?
Semaglutide activates the GLP-1 receptor. A receptor is a cellular protein that receives a chemical signal. Researchers study downstream signaling, including cyclic AMP, and how chemical modifications affect stability and albumin binding.
What are the research questions?
- GLP-1 receptor activation and cellular signaling
- Peptide stability and protein-binding comparisons
- Understanding the distinction between laboratory assays and clinical metabolic outcomes
What does the published work describe?
STEP 1 was a randomized, placebo-controlled trial in adults with overweight or obesity. It evaluated body-weight outcomes over 68 weeks using a defined clinical formulation alongside lifestyle intervention. It was not a study of this catalog reagent or an in-vitro experiment.
Experimental models in the cited papers
- STEP 1: randomized human clinical trial; adults with overweight or obesity
What could future research explore?
Further research can examine receptor responses and formulation-dependent behavior. Clinical questions about long-term metabolic outcomes require evidence from the relevant tested formulation rather than extrapolation from a vial label.
These are research directions, not established applications of the product sold here.
What are the limits of this evidence?
Clinical findings apply to the tested formulation, trial population and study conditions. They do not establish the identity, safety or effectiveness of this laboratory vial. Research Use Only: this material is not a finished medicine.
Study references
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021. PMID 33567185
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is Semaglutide handled in the lab?
For Semaglutide, record the product code SEMA-3, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
Choose a solvent for Semaglutide from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay. For a documented lipid-modified construct, evaluate aggregation and adsorption as well as apparent solubility; check compatibility again after dilution into the final assay buffer.
For Semaglutide, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 4113.58 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
Use the documented storage conditions for the supplied Semaglutide form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
A Semaglutide laboratory protocol should record identity, product code SEMA-3, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- Semaglutide
- CAS Number
- 910463-68-2
- Molecular Weight
- 4113.58 g/mol
- HPLC Purity Specification
- ≥99%
- Category
- GLP-1 & Metabolic
- Starting Price
- $89.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Semaglutide has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
Frequently Asked Questions
What is Semaglutide?
Semaglutide is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 5mg / 10mg / 15mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
What strengths of Semaglutide are available?
The catalog lists 5mg / 10mg / 15mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.
How should I interpret Semaglutide purity results?
Semaglutide has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
How should Semaglutide be handled in the laboratory?
For Semaglutide, record the product code SEMA-3, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
How do I choose a laboratory solvent for Semaglutide?
Choose a solvent for Semaglutide from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay. For a documented lipid-modified construct, evaluate aggregation and adsorption as well as apparent solubility; check compatibility again after dilution into the final assay buffer.
How do I calculate a Semaglutide stock concentration?
For Semaglutide, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 4113.58 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
How should Semaglutide be stored after preparation?
Use the documented storage conditions for the supplied Semaglutide form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
What should a Semaglutide lab protocol document?
A Semaglutide laboratory protocol should record identity, product code SEMA-3, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Does Fmoc or Boc synthesis explain this Semaglutide product?
Fmoc and Boc are peptide protecting-group strategies, not proof of how this Semaglutide lot was made. For sequence-defined peptides, synthesis review can examine deletion products, incomplete deprotection and modifications using the method and matching analytical evidence. A single chromatographic peak does not by itself establish sequence.
Is Semaglutide for human use?
No. Semaglutide is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
